Drug · DIN 02468778
MINT-HYDRALAZINE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 13, 2018; first marketed April 13, 2018.
- Drug Identification Number (DIN)
- 02468778
- Company (DIN owner)
- Mint Pharmaceuticals IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Hydralazine C02DB02
- Class
- Human
- Record last updated
- January 26, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| HYDRALAZINE HYDROCHLORIDE | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 2, 2017: NOC 19874Abbreviated New Drug Submission (ANDS)
Other DINs named MINT-HYDRALAZINE
- DIN 02468786 · Marketed
- DIN 02468794 · Marketed